erythema or induration within 2 cm of the catheter exit site in the absence of associated bloodstream infection and without concomitant purulence Clinical sepsis Requires one of the following with ...

Oregon hospitals have reported a modest decline in health care-associated infections (HAIs) among patients in 2023, according ...

Royal Bank of Canada reissued their outperform rating on shares of CorMedix (NASDAQ:CRMD – Free Report) in a research report ...

The newly released Insights Report, “Improvement in Safety Culture Linked to Better Patient and Staff Outcomes,” highlights ...

D. Boral Capital reaffirmed their buy rating on shares of CorMedix (NASDAQ:CRMD – Free Report) in a research note issued to investors on Tuesday morning,Benzinga reports. They currently have a $15.00 ...

CorMedix ( CRMD -6.01%) Q4 2024 Earnings Call Mar 25, 2025, 8:30 a.m. ET Good day, and welcome to the CorMedix Inc.

CorMedix Inc.'s DefenCath reduces catheter infections by 71%, but the limited market potential challenges long-term adoption.

This study presents a multifunctional nanocomposite coating for catheters, enhancing infection resistance with bioactive and ...